- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Biocon Limited — Important, 25-08-2026: Updates
25-08-2026 | 08:28 am
25-08-2026 | 08:28 am
Biocon's subsidiary received marketing approval for its pegfilgrastim biosimilar in Japan. This strengthens Biocon's portfolio there. Sandoz K.K. will exclusively promote and distribute the product, expanding patient access to high-quality, affordable medications.
No comments yet. Be the first to comment!